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Cell Specificity in DNA Binding and
Repair of Chemical Carcinogens
by James A. Swenberg,* Douglas E. Rickert,*
Bonnie L. Baranyit and Jay 1. Goodmant
Many animal models for organ specific neoplasia have been developed and used to study the
pathogenesis of cancer. Morphologic studies have usually concentrated on the response of target
cells, whereas biochemical investigations have usually employed whole organ homogenates. Since
hepatocytes comprise nearly 90% of the liver's mass and 70-80% of its DNA, alterations in DNA
replication, covalent binding and DNA repair of nonparenchymal cells are usually obscured when
whole organ homogenates are used. By utilizing cell separation methods, we have been able to
demonstrate differences between hepatocyte and nonparenchymal cell replication, DNA damage and
repair following exposure to a variety of hepatocarcinogen. Differences in removal of simple 06-
alkylguanine and DNA replication correlate with cell specific carcinogenesis of simply alkylating
agents. For several other procarcinogens, including 2-acetylaminofluorene and dinitroluene, cell
specificity appears to reside primarily in the differential metabolic competence of hepatocytes and
nonparenchymal cells. This results in greater covalent binding of the carcinogen to hepatocyte DNA,
although the DNA adducts are removed at a similar rate in both cell types.
Introduction
It has long been recognized that many chemical
carcinogens are tissue- or organ-specific (1, 2). Princi-
pal mechanisms thought to be responsible for this
tropism include the absorbtion and distribution of
the compound, site(s) of biotransformation, DNA
binding and repair, and the route of excretion. In
addition to chemicals exhibiting organotropism,
however, most compounds are also cell-specific.
That is, the chemical selectively induces tumors in
specific cell populations within the target organ.
Several examples include the induction of gliomas
in brains of rats by nitrosamides (3); pancreatic islet
cell tumors by streptozotocin (4); liver angiosarco-
mas by 1,2-dimethylhydrazine (SDMH) (5, 6), dimeth-
ylnitrosamine (DMN) (7) and vinyl chloride (8); and
hepatocellular carcinomas by diethylnitrosamine (7,
9), 2-acetylaminofluorene (2-AAF) (10, 11) and dini-
trotoluene (DNT) (12).
Several of the same parameters responsible for
organ specificity are involved in cell-specific carcino-
genesis. Included among these are differences in
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metabolic competence for activating or inactivating
carcinogens, selective effects on cell replication, dif-
ferences in DNA repair, and cell specific enhance-
ment or promotion. The ability to distinguish such
differences between cell populations within the tar-
get organ requires that one be able to separate the
different cell populations. Otherwise, differences
present in smaller populations will be obscured by
changes in the major cell type. For example, the
liver is primarily composed of hepatocytes, bile duct
cells, and sinusoidal lining cells composed of endo-
thelial and Kupffer cells. As noted above, several
chemical carcinogens induce neoplasms of only one
of these cell types. If the chemical causes hepato-
cellular carcinomas, whole liver will probably pro-
vide a reasonable approximation, since 90% of the
liver's mass is composed of hepatocytes (13). Con-
versely however, carcinogens that induce bile duct
carcinomas or vascular tumors of the liver are prob-
ably not well approximated by whole liver, since
bile duct and sinusoidal lining cells comprise only
10-20/ of the liver's cells. Thus, selective increases
in DNA replication and covalent binding or im-
paired DNA repair could go undetected.
Methods for Liver Cell Separation
Several methods are now available for separating
hepatocytes and sinusoidal lining cells. High yields
of sinusoidal lining cells can be obtained by pronaseSWENBERG ETAL.
digestion of hepatocytes in a mixed liver cell sus-
pension (14) following collagenase perfusion of the
liver using the method of Berry and Friend (15). If
both hepatocytes and sinusoidal cells are being in-
vestigated, either elutriation centrifugation (16, 17)
or differential low speed centrifugation (18-20) can
be used. The sinusoidal cells can be further sepa-
rated into Kupffer and endothelial cells by elutria-
tion centrifugation (16). These procedures can be
performed aseptically if tissue culture studies are
required. The techniques provide relatively pure
populations of viable hepatocytes (Fig. la), sinus-
oidal lining cells (Fig. lb), endothelial cells (Fig. lc)
and Kupffer cells (Fig. ld).
Factors Involved in Cell-Specific
Carcinogenesis of Alkylating
Agents
Exposure of rats to 1,2-dimethylhydrazine
(SDMH) results in colon tumors (5, 21) or liver
tumors (5, 6), depending on the dosing regimen.
Nearly 100% of male Fischer-344 rats exposed to 30
ppm SDMH via the drinking water (-2 mg/kg/ day)
developed angiosarcomas of the liver (6). Half of
these animals had metastatic angiosarcoma in their
lungs. Hepatocellular carcinomas also occurred, but
in only 40% of the rats. Using this regimen, we
have examined cell-specific DNA alkylation, repair
and replication during continuous exposure for up
to 4 weeks (6). Similar amounts of 7-methylguanine
(7MG) were formed in both hepatocytes and sinus-
oidal lining cells, suggesting that differential alkyla-
tion is not the mechanism for cell specificity. The
concentrations of 7MG rose from initial one day
values of 320 and 470 pmole/mg DNA in sinusoidal
lining cells and hepatocytes respectively, to 970 and
1020 pmole/mg DNA on day 3 (Fig. 2A). A slight de-
cline to 750 pmole 7MG/mg DNA was noted in both
cell populations after 4 weeks of exposure. This de-
crease in steady-state levels of 7MG could be associ-
ated with either decreased metabolic activation or
c .j S d
FIGURE 1. Photomicrographs of (a) hepatocytes, (b) sinusoidal lining cells, (c) endothelial cells and (d) Kupffer cells separated by
centrifugal elutriation. H & E, x 285.
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0cj ° * s~~~ " Hepatocytes exhibited an extremely rapid decrease
iooo 0 8"* in the O6MG/7MG ratios during the first 3 days and I-0 t° maintained a ratio of 0.005 for the last 25 days of a XU Efi soo 0,,+ . 4-weekexposure (Fig. 2C). * . : We have recently measured the activity of the O6_
alkylguanine alkyl acceptor protein in both cell pop-
0 ulations following continuous exposure of rats to 0 S 10 1S 20 25 30 SDMH (24). A 2- to 3-fold enhancement of this alkyl
acceptor protein occurred in hepatocytes after 3
70 a B. days exposure to SDMH. This high activity was
Z_ 60 .- maintained in hepatocytes throughout the 4-week
z so50 - exposure. In contrast, the sinusoidal lining cells
So . * / \s showed an initial decline in alkyl acceptor protein I_
40 .\ activity, followed by a return to control levels.
X E 30 Thus, the difference in alkylation at the 06 position
o~ 20 -'vs =___ of guanine can be explained by cell-specific differ- 0 ences in DNA repair.
00 10 15 2 2 0 Of equal importance, however, is the cell-specific
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0.15 - (25). The sinusoidal lining cells undergo a marked in-
o C. crease in de novo DNA synthesis, whereas a much
smaller increase in de novo DNA synthesis occurs
in hepatocytes (Fig. 3).
One can approximate the probability of mutation
o.os - due to mispairing of 'MG in replicating DNA tem-
* b ' W * \ , plates for each cell population by multiplying the
O t O\8g_&_@ _@_ _ ____-, , concentration of O6MG, the amount of de novo DNA 0 5 S 10 1S 20 25 30 synthesis and the total amount of DNA at risk (Fig.
DAYS EXPOSURE TO SDMH
FIGURE 2. Normalized concentrations of (A) 7-methylguanine, DPM
(B) 0'-methylguanine and (C) the 06/N-7 alkylation ratios in
sinusoidal lining cells (0) and hepatocytes (0) exposed to 70
30 ppm dimethylhydrazine in the drinking water for in-
tervals up to 28 days. Each data point represents one 60
-
animal, while the curve connects the means of three 6
animals at each time point (6). From Cancer Research with
permission. 50
-
increased removal of 7MG. Support for the former 40 -
is available from previous studies in mice (22) which
demonstrated alterations in DMN metabolism, re- 30 /
sulting in lower formation of 7MG. 7MG-DNA-glyco-
sylase activity has not been measured in liver cells
during continuous oral exposure to SDMH; how-
ever, it was not increased in whole liver homoge-
nates following repeated administration of DMN to 10
rats (23). l
In marked contrast to 7MG, the concentration of 0 5 10 15 20 25 30
the promutagenic DNA adduct, Oi-methylguanine DAYS OF EXPOSURE
(O6MG), was similar in hepatocytes and sinusoidal FIGURE 3. De novo DNA synthesis in (0) sinusoidal lining lining cells only at day 1 of exposure (6). Thereafter, cells and (0) hepatocytes from rats exposed to dimethylhy-
the sinusoidal cells accumulated O6MG, while the drazine in the drinking water for various times (25). From
hepatocytes efficiently removed it (Fig. 2B). The Cancer Research with permission.
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FIGURE 4. Initiation Index for SDMH exposure of rats
represents the probability of mutation due to O6MG. Data
points represent the product of O6MG concentration (6) and
de novo DNA synthesis (25) per mg DNA times the
amount of DNA at risk per cell population for (0)
sinusoidal lining cells and (0) hepatocytes.
4). It is readily apparent that the sinusoidal lining
cells have a greater probability for mutation than
do hepatocytes. These data are consistent with car-
cinogenesis studies at the same dosing regimens (6).
Similar data have been obtained from mice ex-
posed to 100 ppm DMN in their drinking water for
up to 32 days (20). A progressive mitogenic re-
sponse was evident in sinusoidal lining cells from 4
to 32 days of DMN exposure. Hepatocytes main-
tained a relatively constant elevated rate ofde novo
DNA synthesis from 4 to 32 days exposure. The si-
nusoidal lining cells had a progressive increase of
O6MG from 2 to 32 days of DMN exposure, while he-
patocytes maintained relatively constant low con-
centrations of O6MG. At 32 days, the sinusoidal
lining cells had 12 times more OIMG per milligram
DNA than hepatocytes. Thus, the probability of GC
-- AT transitions due to miscoding of O6MG is again
much greater in sinusoidal lining cells, the target
cells for DMN carcinogenesis in the mouse (26).
It must be emphasized that these data only re-
flect the contribution of O6MG to the initiation of
carcinogenesis. The data must be fortified with the
probability of mutation due to other forms of
promutagenic DNA damage, since it is the sum of
mutations due to all promutagenic lesions that is be-
lieved to comprise initiation. Cell specificity in carci-
nogenesis due to alkylating agents will depend on
the ability of different cell populations to activate
the carcinogen, their mitogenic response, their ca-
pacity to remove promutagenic DNA lesions and
the nature of the alkylating agent. For instance, the
major promutagenic lesion produced by SN1 methyl-
ating agents is O6MG (27). It probably represents
the principal lesion responsible for initiation in
those cell types, such as liver sinusoidal cells, that
have low to moderate 06-alkylguanine alkyl acceptor
protein activity (24). O-Alkylated pyrimidines, such
as O2_ and 04-thymine, occur in greater proportion
relative to 06-alkylguanine following exposure to
ethylating agents (27). Since the 0-alkylpyrimidines
are removed from liver DNA more slowly (28, 29),
they may represent the primary lesions responsible
for initiation in those cell types, such as hepatocytes,
that have high 06-alkylguanine alkyl acceptor protein
activity.
Factors Involved in Cell-Specific
Carcinogenesis of N-Substituted
Aryl Compounds
The amount of information available on cell-spe-
cific factors involved in N-substituted aryl carcino-
genesis is more limited than that available for alkyl-
ating agents. Hepatocytes represent the principal
target cell of most hepatocarcinogenic N-substituted
aryl compounds (30). Tumors of bile duct epithelium
also occur, whereas tumors of sinusoidal lining cells
are rare.
2-Acetylaminofluorene
2-Acetylaminofluorene (AAF) is a model hepato-
carcinogen, inducing a high incidence of hepatocellu-
lar carcinomas. Multiple pathways exist for ac-
tivation of AAF to a reactive electrophile. The im-
portance of N-hydroxylation of AAF as the first
step in the hepatocarcinogenic process was con-
firmed when it was found that N-hydroxyacetyl-
aminofluorene (N-OH-AAF) was more potent than
the parent compound in producing tumors of the
liver, mammary gland, small intestine and ear duct
of the rat when given in an equimolar dose (10). In
addition, N-OH- AAF produced tumors at the site of
administration, while AAF was locally inactive (10).
Esterification of theN-hydroxy group of N-OH-AAF
as a result of sulfotransferase or N,O-acyltrans-
ferase activity, and subsequent formation of a
reactive electrophile are steps in the metabolic
pathway thought to be important in hepatic carcino-
genesis following treatment of animals with AAF
(10,31-34).
We have utilized the cell separation methods re-
ferred to above to compare binding of carcinogen
adducts to DNA of hepatocytes and sinusoidal lining
cells following administration of equimolar doses of
AAF or N-OH-AAF.
An assessment of the binding of [ring-3H]-AAF
(1.8 ,umole/100 g) to DNA of hepatocytes and sinus-
oidal lining cells following a single IP injection is
presented in Figure 5. At the time of peak binding,
18 hours post-injection, the ratio of carcinogen ad-
duct per milligram of hepatocyte DNA as compared
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to sinusoidal lining cells was 2.7, indicating an initial
quantitative selectivity of AAF for binding to DNA
of hepatocytes (p < 0.05). After 3 days, 59% of the
adducts remained in DNA of hepatocytes, and 50%
of the adducts remained in DNA of the sinusoidal
lining cells.
The results of analogous studies with [ring-3H]-N-
OH-AAF are presented in Figure 6. Two hours
after a single injection of [ring-3H]-N-OH-AAF (1.8
,umole/100 g), the time of peak DNA binding, there
was no significant difference in the amount of car-
cinogen bound per milligram of hepatocyte and si-
nusoidal lining cell DNA. Three days later, adducts
had been removed from DNA of both cell popula-
tions to a similar extent, i.e., 54% of the adducts re-
mained in DNA of hepatocytes, and 57% of the ad-
ducts remained in DNA of the sinusoidal lining cells.
When these data are adjusted for the amount of
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FIGURE 5. Binding of [ring-3H]AAF to DNA of hepatocytes
(open bars) and sinusoidal lining cells (hatched bars).
Following a single IP injection of [ring-3H]AAF (1.8
imole/100 g), the amount of carcinogen bound/mg DNA
was determined at the time of peak binding (18 hr after
injection) and 3 days later. Results are expressed as the
mean value from six rats. The standard error is
represented by a bar. At 18 hr after injection the amount
of carcinogen bound to the DNA of sinusoidal lining cells
was significantly different (p < 0.05) from that bound to
hepatocytes, as determined by Student's t-test at p =
0.05.
DNA at risk for the two cell populations, the results
clearly show that the amount of carcinogen bound
to the DNA of target cells, i.e., hepatocytes, is much
greater (Table 1). This cell specificity is greatest for
the procarcinogen, AAF, suggesting that hepato-
cytes have greater metabolic competence for N-hy-
droxylating AAF. Support for this hypothesis is
provided by our results with N-OH-AAF, where
similar amounts of covalent binding were present
per milligram DNA. The total amount of N-OH-AAF
bound to hepatocellular DNA versus sinusoidal
lining cell DNA was considerably greater, however.
Thus, cell specificity in N-OH-AAF binding to DNA
would still favor the induction of hepatocellular
tumors.
Previous studies of Tulp et al. reported greater
binding of N-OH-AAF to hepatocyte nuclei than to
stromal cell nuclei (35). Similar differential binding
was present in DNA from these cells. The reason
for the differing results is unknown; however, the
studies may not be directly comparable since the
studies of Tulp et al. utilized a different time point,
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FIGURE 6. Binding of [ring-3H]N-OH-AAF to DNA of
hepatocytes (open bars) and sinusoidal lining cells (hatched
bars). Following a single IP injection of [ring-3H]N-OH-
AAF (1.8 ,Amole/100 g), the amount of carcinogen bound per
mg DNA was determined at the time of peak binding (2 hr
after injection), and 3 days later. Results are expressed as
the mean value from six rats. Standard error is
represented by a bar.
Table 1. Total binding ofAAF and N-OH-AAF to liver cell DNA.
DNA binding, pmole/total DNA Hepatocyte/sinusoidal
Carcinogen Time, hr Hepatocyte Sinusoidal cell Cell ratio
AAF 18 230 43 12 4 19.2
90 95±21 4±1 23.8
N-OH-AAF 2 141 ± 32 17 ± 3 8.3
72 76 31 10 3 7.6
159SWENBERG ETAL.
a different cell separation procedure and a different
DNA isolation method than we used. More recent
studies from the same laboratories using AAF dem-
onstrated similar amounts of the C-8 aminofluorene
adduct in diploid stromal cells and tetraploid and oc-
taploid hepatocytes, but much greater amounts of
the C-8 acetylaminofluorene adduct in hepatocytes.
Likewise, the total amount of covalent binding of
AAF was greatest in hepatocytes, but removal of
DNA adducts was similar in both cell populations
136).
Dinitrotoluene
Dinitrotoluene (DNT) is a high volume commodity
chemical used in the production of explosives and
polyurethane foams. Recent bioassays demon-
strated that DNT was carcinogenic for laboratory
animals (12); however, the target organ differed
with different conditions. 2-4DNT is a potent hepa-
tocarcinogen in Fischer-344 rats (37), with initiating
(38) and promoting (39) activity. It induces a 100%
incidence of hepatocellular carcinomas in male rats
within one year. Females also develop a high in-
cidence of hepatocellular carcinomas; however, the
latency period is somewhat longer. This sex dif-
ference is thought to be due to differences in the
metabolism of DNT (40, 41). DNT is absorbed from
the gastro-intestinal tract and transported to the
liver, where it is metabolized to dinitrobenzyl alcohol
and its glucuronide. In female rats, the glucuronide
enters the general circulation and is primarily ex-
creted in the uring, whereas in males it is excreted
via the bile. The intestinal microflora hydrolyze the
glucuronide and convert the aglycone to an as yet
unidentified metabolite that is reabsorbed and
transported to the liver. On this second pass through
the liver, the unknown metabolite is covalently
bound to hepatic macromolecules or is converted to a
reactive species capable ofcovalent binding.
We have initiated studies to characterize the ex-
tent and persistence of 2,6-DNt'covalent binding in
hepatocytes and sinusoidal lining cells of male and
female Fischer-344 rats in order to determine
whether sex-dependent differences in DNA modifi-
cation exist and whether covalent binding is greater
in hepatocytes, the target cell for DNT carcinogene-
sis, than in the nontarget sinusoidal lining cell popu-
lations. Nine male and nine female Fischer-344 rats
were dosed orally with 35 mg/kg 3H-2,6-DNT (250
,Ci/rat). At 0.5, 4 or 7 days, the livers of three rats
of each sex were perfused with collagenase and
their hepatocytes and sinusoidal lining cells sepa-
rated by differential centrifugation. DNA was iso-
lated from hepatocytes of individual rats, whereas
the sinusoidal lining cells from all three animals
were pooled prior to DNA isolation. The extent of
covalent binding was determined by scintillation
counting. DNA was measured using the diamino-
benzoic acid method (42). Data expressed as
DPM/mg DNA are shown in Figure 7, while total co-
valent binding per cell population is shown in Fig-
ure 8. DNA from male hepatocytes exhibited the
greatest amount of covalent binding. DNA from fe-
male hepatocytes had slightly less initial binding.
Covalently bound DNT was removed from hepato-
cyte DNA more rapidly during the first 4 days after
exposure than during the subsequent 3 days. While
the data on sinusoidal lining cells were limited due
to pooling of samples, there was considerably less
2,6-DNT bound to their DNA and minimal evidence
of DNA repair. For comparison, three germ-free
male Fischer-344 rats were also examined for cova-
lent binding to DNA 12 hours after exposure to 3H-
2,6-DNT. Hepatocellular DNA from the germ-free
rats contained less than 10% of the amount of 2,6-
DNT bound to DNA of conventional animals (Figs. 7
and 8).
When male rats were given weekly doses of 3H-
2,6-DNT (35 mg/kg, 250 MCi/rat) and killed 7 days
later, covalently bound radioactivity accumulated
only in hepatocellular DNA (Fig. 9). Thus, the extent
of covalent binding of 3H-2,6-DNT exhibits a strong
correlation in both cell and sex specificity. Addi-
tional investigations will be necessary to determine
the nature of the covalently bound material. Prelim-
inary data have demonstrated the presence of a
single radioactive peak following HPLC separation
of nucleosides.
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FIGURE 7. Covalent binding (DPM/mg DNA of 3H-2,6-DNT
(250 ,uCi, 35 mg/kg orally) in DNA from male (W,E) and
female (0,0 ) rat hepatocytes (l,04,) and sinusoidal lining
cells (U, *,A). Male germ-free rats (A,A) have much lower
amounts of covalent binding. Hepatocyte data points
I represent the mean of three rats, while sinusoidal lining
cells from three rats were pooled for a single deter-
mination.
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FIGURE 8. Data from Figure 7 expressed as total covalent
binding to DNA for each cell population, using average
yields of 1 mg DNA for sinusoidal lining cells and 7 mg
DNA for hepatocytes.
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FIGURE 9. Cumulative covalent binding of 3H-2,6-DNT to
DNA. Male F-344 rats received 250 MCi (35 mg/kg) orally
for 1, 2, 3 or 4 weeks. Hepatocytes (O) or sinusoidal lining
cells (U) were isolated one week after the last dose. Data
are expressed as DPM bound to the total DNA per cell
population using pooled sinusoidal lining cells and the
mean of three individual rats' hepatocytes.
Conclusions
Tissue and cell specificity in chemical carcinogen-
esis depends on a multiplicity of factors including
the dose and route of exposure, absorption and
distribution, the requirement for and site of bio-
transformation, chemical reactivity with DNA, the
cellular capacity for repairing promutagenic DNA
lesions and the amount of cell replication that takes
place prior to such repair. Expression of these early
events in chemical carcinogenesis is further compli-
cated by exposure to promoting agents and toxins
that selectively expand populations of initiated cells.
Cellular tropism for specific chemicals will be in-
fluenced to different degrees by these factors. For
example, high doses of aklylating agents will satu-
rate the efficient hepatocyte 06-alkylguanine alkyl
acceptor protein repair system (43), resulting in a
greater likelihood for cell replication and resultant
fixation ofa GC ->AT transitions. Compensatory cell
proliferation following selective toxicity is also dose-
dependent. The magnitude of dose or concommitant
exposure to other agents can also influence the site
of biotransformation. Low oral doses ofDMN are ex-
clusively metabolized in the liver, whereas higher
doses are activated in kidney (44). Selenium can se-
lectively decrease SDMH metabolism in liver, result-
ing in increased systemic alkylation (45).
Metabolic differences between male and female
rats result in greater covalent binding and subse-
quent tuinor formation with AAF and DNT. Within
the target organ, the metabolic competence of dif-
ferent cell populations affects the extent of DNA ad-
duct formation as well as toxicity-induced compen-
satory cell proliferation. In most instances, this re-
sults in greater adduct formation in hepatocytes,
both in terms of adducts per milligram DNA and ad-
ducts per total cell population. For chemicals such
as AAF, removal of covalently bound carcinogen
was similar in hepatocyte and sinusoidal lining cells,
whereas major differences were apparent for re-
moval of 06-alkylguanine. In the latter case, cell
specificity becomes dependent on chemical reactiv-
ity with DNA. For example, the major promuta-
genic lesion induced by DNA by SN1 methylating
agents is O6MG (46). O6MG will therefore represent
the major lesion responsible for initiation in those
cell types, such as liver sinusoidal lining cells and
neuroglial cells, that have low to moderate 0f-alkyl-
guanine alkyl acceptor protein activity (24). On the
other hand, ethylating agents produce a greaer pro-
portion of 0-alkylated promutagenic pyrimidines
relative to 0-alkylation of guanine. These 0-alkyl-
ated pyrimidines are removed from hepatocyte
DNA much more slowly (28, 29), providing promi-
nent templates for mutations in cells that have high
0W-alkylguanine alkyl acceptor protein activity and
efficient removal of0f-alkylguanine.
Last, it is difficult to overestimate the importance
of cell replication in chemical carcinogenesis. Muta-
tions in a given cell population result from mis-
coding of promutagenic damage in the parental
strand during DNA replication. The mutations fixed
in the daughter strand are amplified in succeeding
generations through cell replication. This can occur
at an enhanced rate due to selective cytotoxicity or
specific promotion by the carcinogen or by exposure
to other agents. Understanding the complex process
ofchemical carcinogenesis will require quantification
ofthese individual components atthe cellular level.
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